To investigate endogenously expressed EVI1 in AML we studied 3q26 rearranged SB1690CB AML cells, which express high levels of both EVI1 and ΔEVI1, but no MDS-EVI1 (Fig. 1a) [6]. This evidence concerns the gene MECOM and acute myeloid leukemia.